MedTrace Logo

Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer

NCT02295956 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2019-06-12

No results posted yet for this study

Summary

The goal of this research study is to learn if it is possible to start a home-based exercise and nutrition program for patients with pancreatic cancer or who may have pancreatic cancer before surgery (pre-operative rehabilitation, also known as prehabilitation).

Conditions

Interventions

BEHAVIORAL

Questionnaires

Series of physical and quality of life assessments administered to participants, taking about 20 minutes to complete.

OTHER

Exercise

Participants instructed to perform resistance/strengthening exercises for 30 minutes two times each week. Participants to walk 20-30 minutes at least 3 times a week. Participants issued a set of 3 resistance exercise bands with which the exercises can be performed.

OTHER

Nutrition Counseling

Within 7 days after being enrolled on study, participant meets with a dietitian to discuss nutrition.

BEHAVIORAL

Phone Calls

Participants receive phone calls from study staff every 2 weeks for 6 weeks to check for adherence, and if they are having any side effects from the exercise.

OTHER

Booklet

Exercise instructional booklet given to all participants describing all exercises.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Matthew H. Katz, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-02
Primary Completion
2019-06-06
Completion
2019-06-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02295956 on ClinicalTrials.gov